Loading...
IDEX Corp (IEX) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company has strong financial performance, positive analyst sentiment with raised price targets, and bullish technical indicators. Despite a neutral options sentiment and lack of significant insider or hedge fund trading trends, the stock's fundamentals and growth potential make it a solid choice for long-term investment.
The technical indicators for IEX are bullish. The MACD is positive and contracting, suggesting a potential upward momentum. The RSI is neutral at 45.148, indicating no overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near a key support level of 199.246, with resistance at 207.125 and 215.003.

Strong Q4 2025 financial performance with revenue, net income, and EPS growth.
Analysts have raised price targets significantly, with multiple firms maintaining Buy or Outperform ratings.
Health and Science Technologies segment shows robust growth, with a 34% increase in organic orders.
Neutral sentiment from hedge funds and insiders with no significant trading trends.
Short-term stock trend analysis suggests a potential minor decline in the next day, week, and month.
In Q4 2025, IDEX Corp reported revenue growth of 4.20% YoY to $899.1M, net income growth of 4.14% YoY to $128.3M, and EPS growth of 6.17% YoY to $1.72. Gross margin increased by 1.20% YoY to 43.05%, indicating strong operational efficiency.
Analysts are overwhelmingly positive on IEX, with multiple firms raising price targets to the $240-$250 range and maintaining Buy or Outperform ratings. They cite strong orders, improving growth prospects, and solid Q4 performance as key drivers for their optimism.